* Mandatory fields
The Australian Government today released the report of the Therapeutic Goods Administration (TGA) Transparency Review panel, chaired by Professor Dennis Pearce.
This year's Melbourne IAC annual dinner was held Thursday December 5th in Ethiad Stadium, Docklands, Melbourne. The event, sandwiched between the opening and closing nights of U2's 360oC tour allowed the 97 registrants to enjoy drinks on the stadi
The ARCS Business Office, on behalf of the Board is pleased to announce the results of the elections held at our AGM on 3 November at the Kirribilli Club.
Sarahann Simpson, Teresa Schafer, Trevor Schoerie and James Bryden were returned for
Congratulations to all those involved in organising the very successful Canberra Congress especially the hard work invested by the ARCS team in the Business Office. As board members, we proudly accepted a multitude of positive comments about the p
Our small dedicated office has been moving forward with new initiatives and growth in line with the ARCS Strategic Plan. We are putting in place the necessary steps to support the ARCS Asia organization that will be formed shortly. The audit has b
The ARCS Australia Board is delighted to announce the appointment of Adrian Bootes as new CEO of ARCS Australia – his first day in the role will be 2nd August 2010.
Adrian has been an active ARCS member since 1993, during this time,
A working group associated with the NZ Association of Clinical Research is developing a standardized CTRA along the lines of the Agreement developed in Australia. It will include a Schedule 7 and they are currently seeking input on Schedule 7 chan
The TGA has released its new fee scale, along with an accompanying summary and explanatory note. Full information can be found at http://www.tga.gov.au/fees/fees10.htm.
This was so great – and it is only the beginning! The “second half” of ARCS Scientific Congress for 2010 is coming up in September and registrations open in July! Read on to reflect on Sydney or to see what you missed!
At the ARCS Board meeting on the 21st January 2010, the first three ARCS Certified Fellows (ACF) in clinical research were approved by the ARCS Board. These individuals are:
- Katrina Campion, Senior Clinical Research Manager, (Australia
NHMRC’s Council has agreed with a recommendation from the Australian Health Ethics Committee that a minor amendment be made to the 2007 National Statement on Ethical Conduct in Human Research. This change affects the chapter on People wi
Recent research conducted amongst our members - and in consultation with senior members in management positions - has identifi ed the need for Certifi cation. Therefore, members of ARCS Australia Ltd are now able to gain recognition for their trai
Queensland Health (QH) tendered has appointed DLA Phillips Fox to provide legal services across all sites in QH for the review and advice on non standard clinical trial/research agreements. This initiative should assist in streamlining the legal revi
ARCS is pleased to be associated with the Clinical Trial Magnifier 2009 Conference as a Supporting Organisation. The Conference will be held on November 13-15, 2009 at The University of Hong Kong. We encourage you to provide this information to yo
NHMRC's Australian Health Ethics Committee has developed a revised Position Statement: Monitoring and Reporting of Safety for Clinical Trials Involving Therapeutic Products. This statement replaces the HREC Alert issued by NHMRC on 18 April 2007 a
The NSW Department of Health has updated its policy directive on the use of standard CTRAs. There is no substantive change, except for the inclusion of CRO CTRA. To review the changes, please visit the NSW Health website and sc
ARCS is delighted to announce the appointment of Insurance House Group as our preferred Professional Indemnity insurance provider for members. Insurance House Group has been established for 25 years, employs 55 staff and is one of Australia’
In these harsh economic times when many businesses and activities are seeing a downturn, the ARCS 18th Annual Scientific Congress defied the odds by attracting 1,168 delegates – a 5% increase on last year’s figures.
Yes – it's over for another year, but it was a great success! 1052 registered delegates enjoyed the Congress – and in total, 1150 interested parties walked through our doors which included final year and post-grad students intereste
The Annual General Meeting of the Association of Regulatory and Clinical Scientists to the Australian Pharmaceutical Industry Ltd (ARCS) yesterday voted to change the name of the Association to ARCS Ltd and to adopt a new Con
They may not be dressed in white lab coats, but the scientists who attended the educational day and Annual General Meeting of the Association of Regulatory and Clinical Scientists (ARCS; www.arcs.com.au) in Sy
© ARCS Australia
2013 | Code Of Conduct | Privacy Statement | Terms & Conditions | Site Map | Contact Us